Pharmacotherapy of obesity

Por Wilding, John P. H.
Publicado em 2008

Management of hypertension : Ideal body weight is not realistic goal for lifestyle intervention

Por Wilding, John, Williams, Gareth
Publicado em 2000

Modern management of obesity

Por Aditya, Bhandari Sumer, Wilding, John PH
Publicado no Clin Med (Lond) (2009)

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus

Por Budoff, Matthew J., Wilding, John P. H.
Publicado no Int J Clin Pract (2017)

1,25-dihydroxyvitamin D(3) Protects against Macrophage-Induced Activation of NFκB and MAPK Signalling and Chemokine Release in Human Adipocytes

Por Ding, Cherlyn, Wilding, John P. H., Bing, Chen
Publicado em 2013

Anti-obesity drugs: past, present and future

Por Rodgers, R. John, Tschöp, Matthias H., Wilding, John P. H.
Publicado em 2012

Delineation of early attentional control difficulties in fragile X syndrome: Focus on neurocomputational changes

Por Scerif, Gaia, Cornish, Kim, Wilding, John, Driver, Jon, Karmiloff-Smith, Annette
Publicado em 2007

Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y

Por Brown, Michael, Bing, Chen, King, Peter, Pickavance, Lucy, Heal, David, Wilding, John
Publicado em 2001

The dual PPARα/γ agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats

Por Pickavance, Lucy C, Brand, Christian L, Wassermann, Karsten, Wilding, John P H
Publicado em 2005

Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study

Por Wilding, John, Bailey, Clifford, Rigney, Una, Blak, Betina, Beekman, Wendy, Emmas, Cathy
Publicado no Diabetes Ther (2016)

Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and β-cell apoptosis in the pancreas of the Zucker Diabetic F...

Por Pickavance, Lucy C, Widdowson, Peter S, Foster, John R, Williams, Gareth, Wilding, John P H
Publicado em 2003

A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers: Applicability of a novel insulin-independent treatment

Por Wilding, John P.H., Norwood, Paul, T'joen, Caroline, Bastien, Arnaud, List, James F., Fiedorek, Fred T.
Publicado em 2009

Differential vascular dysfunction in response to diets of differing macronutrient composition: a phenomenonological study

Por Fatani, Sameer, Pickavance, Lucy C, Sadler, Claire J, Harrold, Joanne A, Cassidy, Roslyn, Wilding, John PH, Naderali, Ebrahim K
Publicado em 2007

Altered Left Ventricular Ion Channel Transcriptome in a High-Fat-Fed Rat Model of Obesity: Insight into Obesity-Induced Arrhythmogenesis

Por Ashrafi, Reza, Yon, Marianne, Pickavance, Lucy, Yanni Gerges, Joseph, Davis, Gershan, Wilding, John, Jian, Kun, Zhang, Henggui, Hart, George, Boyett, Mark
Publicado no J Obes (2016)

Absence of insulin signalling in skeletal muscle is associated with reduced muscle mass and function: evidence for decreased protein synthesis and not increased degradation

Por O’Neill, Elaine D., Wilding, John P. H., Kahn, C. Ronald, Van Remmen, Holly, McArdle, Anne, Jackson, Malcolm J., Close, Graeme L.
Publicado em 2010

Charting the developmental trajectories of attention and executive function in Chinese school-aged children

Por Zhan, Jian-Ying, Wilding, John, Cornish, Kim, Shao, Jie, Xie, Chun-Hong, Wang, Yan-Xia, Lee, Kang, Karmiloff-Smith, Annette, Zhao, Zheng-Yan
Publicado em 2011

Effects of canagliflozin on body weight and relationship to HbA(1c) and blood pressure changes in patients with type 2 diabetes

Por Cefalu, William T., Stenlöf, Kaj, Leiter, Lawrence A., Wilding, John P. H., Blonde, Lawrence, Polidori, David, Xie, John, Sullivan, Daniel, Usiskin, Keith, Canovatchel, William, Meininger, Gary
Publicado no Diabetologia (2015)

Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers

Por Fujioka, Ken, O'Neil, Patrick M., Davies, Melanie, Greenway, Frank, C.W. Lau, David, Claudius, Birgitte, Skjøth, Trine Vang, Bjørn Jensen, Christine, P.H. Wilding, John
Publicado no Obesity (Silver Spring) (2016)

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials

Por O'Neil, Patrick M., Aroda, Vanita R., Astrup, Arne, Kushner, Robert, Lau, David C. W., Wadden, Thomas A., Brett, Jason, Cancino, Ana‐Paula, Wilding, John P. H.
Publicado no Diabetes Obes Metab (2017)

Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment

Por Seetho, Ian W, Ramírez-Torres, Adela, Albalat, Amaya, Mullen, William, Mischak, Harald, Parker, Robert J, Craig, Sonya, Duffy, Nick, Hardy, Kevin J, Burniston, Jatin G, Wilding, John PH
Publicado no Sleep Sci (2015)